© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 27, 2020
New data presented at ACG 2020 shows NER1006 bowel preparation to be safe and efficacious in patients with diabetes preparing for their colonoscopy.
An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.
New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.
New phase 1 data show the first-in-class oral therapy is not affected by the burden on metabolism via hepatic or renal disease.
October 26, 2020
Research shows dupilumab remains effective in EoE for up to 2 years.
A new study presented at ACG shows vedolizumab to be superior to adalimumab in maintaining early disease control in patients with moderate-to-severe ulcerative colitis.
In a poster presented during ACG, investigators show data from a long-term extension of the UNIFI trial.
Patients with chronic pancreatitis can exhibit dependence on chronic opioid therapy prior to receiving total pancreatectomy with islet autotransplantation.
Isolation as a result of suspected C. Diff can take a significant financial toll on the healthcare system, thus it is necessary to determine appropriate factors that can predict CDI.
October 25, 2020
The double-blind trial reported on long-term cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.